Verastem Oncology (VSTM) 2014年年度报告「NASDAQ」.pdf

1、Use these links to rapidly review the documentTABLE OF CONTENTS Verastem,Inc.CONSOLIDATED FINANCIAL STATEMENTSTable of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-KCommission file number 001-35403Verastem,Inc.(Exact name of registrant as specified in its chart

2、er)Delaware(State or other jurisdiction ofincorporation or organization)27-3269467(I.R.S.EmployerIdentification No.)117 Kendrick Street,Suite 500Needham,Massachusetts(Address of principal executiveoffices)02494(Zip Code)Registrants telephone number,including area code:(781)292-4200 Securities regist

3、ered pursuant to Section 12(b)of the Act:Title of each class Name of each exchange on which registeredCommon Stock,$0.0001 parvalue NASDAQ Global Market Securities registered pursuant to Section 12(g)of the Act:None Indicate by check mark if the registrant is a well-known seasoned issuer,as defined

4、in Rule 405 of the Securities Act.o Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.o Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Secur

5、ities Exchange Act of 1934during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filingrequirements for the past 90 days.Yes o No Indicate by check mark whether the registrant has submitted electronically and po

6、sted on its corporate Website,if any,every Interactive Data Filerequired to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorterperiod that the registrant was required to submit and post such files).Yes o No Indicat